CASEY’S GENERAL STORES, INC. vs CVS HEALTH CORPORATION, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CASY and CVS diverge most: on ev/ebitda, CASY reads 213.5 and CVS reads 13.3; on dividend yield, CASY reads 0.3% and CVS reads 2.8%. The rest of the comparable metrics sit closer together. What CVS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CASY | CVS |
|---|---|---|
| Price | $615.56 | $94.67 |
| Market cap | $22.9B | $121.8B |
| Sector | Retail | Retail |
| Stage | Growth | Mature |
| Implied growth (priced in) | +10.9% | — |
| P/E | 29.6 | 25.0 |
| P/B | 5.58 | 1.52 |
| P/S | 1.22 | 0.29 |
| EV/EBITDA | 213.5 | 13.3 |
| Revenue growth | +13.3% | +7.3% |
| Operating margin | — | 4.4% |
| Net margin | 4.1% | 0.7% |
| Return on equity | 18.9% | 3.7% |
| Return on assets | 8.5% | 1.2% |
| Return on invested capital | — | 4.5% |
| FCF yield | 2.8% | 9.7% |
| Dividend yield | 0.3% | 2.8% |
| Debt / equity | 0.59 | 0.74 |
| Current ratio | 1.02 | 0.87 |
| Altman Z (solvency) | 5.41 | 2.42 |
| Piotroski F (quality) | 7 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.